Clinical Trial Update: Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjunct Immunoxel immunotherapy in tuberculosis patients, including those coinfected with HIV, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Immunoxel

Snippet

Sponsor: Lisichansk Regional Tuberculosis Dispensary | Conditions: Tuberculosis, HIV | Phase 3 | Status: COMPLETED